Burleson & Co’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
AWA
Burleson & Co's MRK Position: Q4 2022 in Review
Burleson & Co increased its Merck (MRK) stake by 25% in Q4 2022, buying an estimated $383K and bringing the position to 18,438 shares worth $2.05M. The position accounts for 0.51% of the portfolio, ranked #58.
Burleson & Co first reported a position in MRK in Q4 2017 and has held it in 21 quarters since. 3,235 funds tracked by Wall St. Rank hold MRK as of Q4 2022.
- Burleson & Co held 18,438 shares of Merck worth $2.05M as of Q4 2022.
- Burleson & Co bought 3,746 Merck shares in Q4 2022, an estimated $383K.
- Merck made up 0.51% of Burleson & Co's portfolio in Q4 2022, its #58 holding.
- Burleson & Co first reported a position in Merck in Q4 2017 and has held it in 21 quarters since.
- 3,235 funds tracked by Wall St. Rank held Merck as of Q4 2022.
Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.